November 2021; papers of the month
The Resus Room
00:00
Do the Drugs Increase Rosk Rates in Inpatient Cardiac Patients?
Vase pressin and methar pradnissalone, compared to plasebo, gives you a higher rosrate. But although rosk is achieved, it doesn't translate to any improved outcomes at 30 or 90 days,. So there's a cost implication from this. And i wonder whether or not this is actually a study that's been created to see he rosk can be achieved more significantly with these treatments. It could make for either better or worse outcomes in the long run, we just don't know.
Transcript
Play full episode
